首页> 外文期刊>The Journal of toxicological sciences >In vivo hepatotoxicity study of rats in comparison with in vitro hepatotoxicity screening system.
【24h】

In vivo hepatotoxicity study of rats in comparison with in vitro hepatotoxicity screening system.

机译:大鼠体内肝毒性研究与体外肝毒性筛选系统的比较。

获取原文
获取原文并翻译 | 示例
       

摘要

For the establishment of a high throughput screening system using primary cell cultures, investigation of elucidated toxicities to assess the correlation between in vitro and in vivo hepatotoxicity is necessary in the safety evaluation of the compound. In the previous study, we reported the usability of rat primary cultured hepatocytes for establishment of high throughput screening system. To confirm the reliability of rat primary hepatocytes culture screening system, we conducted a single-dose in vivo study with relatively high dose of hepatotoxicant in rats using 4 reference compounds (acetaminophen, amiodarone, tetracycline, carbon tetrachloride), and investigated histopathological changes and expression of oxidative stress-related proteins by immunohistochemistry. We also carried out a proteomics analysis for estimating the reliable and sensitive biomarkers. Histopathologically, compound-specific hepatotoxicity was detected at 24 hr after administration in all compounds except amiodarone, which is known to induce phospholipidosis. Immunohistochemically, oxidative stress-related proteins were increased within 6 hr after administration in all treated groups. Proteomics analysis revealed several protein biomarkers related to oxidative stress and mitochondrial metabolism-regulation, which had been previously detected by proteomics analysis in in vitro screening system. Oxidative stress-related proteins were considered as useful biomarkers of hepatotoxicity; since they were detected by immunohistochemistry and proteomics analysis prior to appearance of compound-specific histopathological changes detected by light microscopy. Considering the relevance of in vitro system to in vivo system from the aspect of new biomarkers related to the toxicogenomics/toxicoproteomics, in vitro primary cell culture system would be sufficient to detect hepatotoxicity in the early stage of drug discovery.
机译:为了建立使用原代细胞培养物的高通量筛选系统,在化合物的安全性评估中必须研究阐明的毒性以评估体外和体内肝毒性之间的相关性。在先前的研究中,我们报道了大鼠原代培养的肝细胞在建立高通量筛选系统中的可用性。为了证实大鼠原代肝细胞培养筛选系统的可靠性,我们使用4种参考化合物(对乙酰氨基酚,胺碘酮,四环素,四氯化碳)在大鼠中进行了相对高剂量肝毒性的单剂量体内研究,并研究了其组织病理学变化和表达免疫组化技术检测氧化应激相关蛋白我们还进行了蛋白质组学分析,以评估可靠和敏感的生物标志物。在组织病理学上,除胺碘酮(已知会引起磷脂酰化)外,所有化合物在给药后24小时均检测到化合物特异性的肝毒性。在免疫组织化学上,所有治疗组在给药后6小时内氧化应激相关蛋白均增加。蛋白质组学分析揭示了与氧化应激和线粒体代谢调节相关的几种蛋白质生物标记物,这些蛋白质生物标记物先前已通过蛋白质组学分析在体外筛选系统中检测到。氧化应激相关蛋白被认为是肝毒性的有用生物标志物。因为它们是在通过光学显微镜检测到的化合物特异性组织病理学改变出现之前通过免疫组织化学和蛋白质组学分析检测到的。从与毒理基因组学/毒理基因组学相关的新生物标志物的角度考虑体外系统与体内系统的相关性,体外原代细胞培养系统将足以在药物发现的早期阶段检测肝毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号